Cancer BiologybioRxivPreprint
A first-in-class multimodal organomercury compound demonstrates preferential blast reduction with improved hematopoietic and immune health in ALL
Sougata Mondal, Olina Ghosh, Basab Bagchi…·Supratim Ghosh
This study evaluates -Mercurin, a new organomercury compound, showing better blast reduction and improved hematopoietic and immune health in a rat ALL model compared to cytarabine.
DOI 10.64898/2026.07.18.739301